Your browser doesn't support javascript.
loading
Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with 18F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles.
Lohith, Talakad G; Bennacef, Idriss; Vandenberghe, Rik; Vandenbulcke, Mathieu; Salinas, Cristian A; Declercq, Ruben; Reynders, Tom; Telan-Choing, N Florestina; Riffel, Kerry; Celen, Sofie; Serdons, Kim; Bormans, Guy; Tsai, Kuenhi; Walji, Abbas; Hostetler, Eric D; Evelhoch, Jeffrey L; Van Laere, Koen; Forman, Mark; Stoch, Aubrey; Sur, Cyrille; Struyk, Arie.
Afiliación
  • Lohith TG; Translational Biomarkers, Merck & Co., Inc., West Point, Pennsylvania.
  • Bennacef I; Translational Biomarkers, Merck & Co., Inc., West Point, Pennsylvania.
  • Vandenberghe R; Neurology Department, University Hospitals Leuven, Leuven, Belgium; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium; Alzheimer Research Centre, KU Leuven, Leuven Institute for Neuroscience and Disease, Leuven, Belgium.
  • Vandenbulcke M; Neurology Department, University Hospitals Leuven, Leuven, Belgium; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium; Alzheimer Research Centre, KU Leuven, Leuven Institute for Neuroscience and Disease, Leuven, Belgium.
  • Salinas CA; Translational Biomarkers, Merck & Co., Inc., West Point, Pennsylvania.
  • Declercq R; Translational Pharmacology Europe, Merck Sharp & Dohme Corp., Brussels, Belgium.
  • Reynders T; Translational Pharmacology Europe, Merck Sharp & Dohme Corp., Brussels, Belgium.
  • Telan-Choing NF; Translational Pharmacology Clinical Operations, Merck & Co., Inc., North Wales, Pennsylvania.
  • Riffel K; Translational Biomarkers, Merck & Co., Inc., West Point, Pennsylvania.
  • Celen S; Radiopharmaceutical Research, KU Leuven, Leuven, Belgium.
  • Serdons K; Division of Nuclear Medicine, University Hospitals Leuven and UZ Leuven, Leuven, Belgium.
  • Bormans G; Radiopharmaceutical Research, KU Leuven, Leuven, Belgium.
  • Tsai K; Early Clinical Statistics, Merck & Co., Inc., West Point, Pennsylvania.
  • Walji A; Discovery Chemistry, Merck & Co., Inc., West Point, Pennsylvania; and.
  • Hostetler ED; Translational Biomarkers, Merck & Co., Inc., West Point, Pennsylvania.
  • Evelhoch JL; Translational Biomarkers, Merck & Co., Inc., West Point, Pennsylvania.
  • Van Laere K; Division of Nuclear Medicine, University Hospitals Leuven and UZ Leuven, Leuven, Belgium.
  • Forman M; Translational Pharmacology, Merck & Co., Inc., North Wales, Pennsylvania.
  • Stoch A; Translational Pharmacology, Merck & Co., Inc., North Wales, Pennsylvania.
  • Sur C; Translational Biomarkers, Merck & Co., Inc., West Point, Pennsylvania.
  • Struyk A; Translational Pharmacology, Merck & Co., Inc., North Wales, Pennsylvania arie_struyk@merck.com.
J Nucl Med ; 60(1): 107-114, 2019 01.
Article en En | MEDLINE | ID: mdl-29880509

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Encéfalo / Radioisótopos de Flúor / Ovillos Neurofibrilares / Tomografía de Emisión de Positrones / Enfermedad de Alzheimer / Isoquinolinas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Nucl Med Año: 2019 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Encéfalo / Radioisótopos de Flúor / Ovillos Neurofibrilares / Tomografía de Emisión de Positrones / Enfermedad de Alzheimer / Isoquinolinas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Nucl Med Año: 2019 Tipo del documento: Article